239 related articles for article (PubMed ID: 33832505)
1. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
2. Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.
Ye Q; Kantonen S; Gomez-Cambronero J
J Mol Biol; 2013 Feb; 425(4):755-66. PubMed ID: 23238254
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.
Su W; Yeku O; Olepu S; Genna A; Park JS; Ren H; Du G; Gelb MH; Morris AJ; Frohman MA
Mol Pharmacol; 2009 Mar; 75(3):437-46. PubMed ID: 19064628
[TBL] [Abstract][Full Text] [Related]
4. β-Heregulin impairs EGF induced PLC-γ1 signalling in human breast cancer cells.
Rommerswinkel N; Keil S; Adawy A; Hengstler JG; Niggemann B; Zänker KS; Dittmar T
Cell Signal; 2018 Dec; 52():23-34. PubMed ID: 30165102
[TBL] [Abstract][Full Text] [Related]
5. Novel lipid-soluble thiol-redox antioxidant and heavy metal chelator, N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI) and phospholipase D-specific inhibitor, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) attenuate mercury-induced lipid signaling leading to protection against cytotoxicity in aortic endothelial cells.
Secor JD; Kotha SR; Gurney TO; Patel RB; Kefauver NR; Gupta N; Morris AJ; Haley BE; Parinandi NL
Int J Toxicol; 2011 Dec; 30(6):619-38. PubMed ID: 21994240
[TBL] [Abstract][Full Text] [Related]
6. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
[TBL] [Abstract][Full Text] [Related]
7. A novel role for phospholipase D as an endogenous negative regulator of platelet sensitivity.
Elvers M; Grenegård M; Khoshjabinzadeh H; Münzer P; Borst O; Tian H; Di Paolo G; Lang F; Gawaz M; Lindahl TL; Fälker K
Cell Signal; 2012 Sep; 24(9):1743-52. PubMed ID: 22579635
[TBL] [Abstract][Full Text] [Related]
8. Critical role for the catalytic activity of phospholipase C-gamma1 in epidermal growth factor-induced cell migration.
Xie Z; Peng J; Pennypacker SD; Chen Y
Biochem Biophys Res Commun; 2010 Aug; 399(3):425-8. PubMed ID: 20674545
[TBL] [Abstract][Full Text] [Related]
9. Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.
Ganesan R; Mahankali M; Alter G; Gomez-Cambronero J
Biochim Biophys Acta; 2015 Mar; 1851(3):261-72. PubMed ID: 25532944
[TBL] [Abstract][Full Text] [Related]
10. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR.
Dittmar T; Husemann A; Schewe Y; Nofer JR; Niggemann B; Zänker KS; Brandt BH
FASEB J; 2002 Nov; 16(13):1823-5. PubMed ID: 12354693
[TBL] [Abstract][Full Text] [Related]
11. Reversible bleb formation in mast cells stimulated with antigen is Ca2+/calmodulin-dependent and bleb size is regulated by ARF6.
Yanase Y; Carvou N; Frohman MA; Cockcroft S
Biochem J; 2009 Dec; 425(1):179-93. PubMed ID: 19845506
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.
Stegner D; Thielmann I; Kraft P; Frohman MA; Stoll G; Nieswandt B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2212-7. PubMed ID: 23868933
[TBL] [Abstract][Full Text] [Related]
13. Analysis of platelet-derived growth factor-induced phospholipase D activation in mouse embryo fibroblasts lacking phospholipase C-gamma1.
Hess JA; Ji QS; Carpenter G; Exton JH
J Biol Chem; 1998 Aug; 273(32):20517-24. PubMed ID: 9685408
[TBL] [Abstract][Full Text] [Related]
14. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
15. Antitumour effects of PLC-gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells.
Katterle Y; Brandt BH; Dowdy SF; Niggemann B; Zänker KS; Dittmar T
Br J Cancer; 2004 Jan; 90(1):230-5. PubMed ID: 14710234
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.
Patel RB; Kotha SR; Sherwani SI; Sliman SM; Gurney TO; Loar B; Butler SO; Morris AJ; Marsh CB; Parinandi NL
Int J Toxicol; 2011 Feb; 30(1):69-90. PubMed ID: 21131602
[TBL] [Abstract][Full Text] [Related]
17. Grb2 negatively regulates epidermal growth factor-induced phospholipase C-gamma1 activity through the direct interaction with tyrosine-phosphorylated phospholipase C-gamma1.
Choi JH; Hong WP; Yun S; Kim HS; Lee JR; Park JB; Bae YS; Ryu SH; Suh PG
Cell Signal; 2005 Oct; 17(10):1289-99. PubMed ID: 16038803
[TBL] [Abstract][Full Text] [Related]
18. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
Stieglitz KA
Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
[TBL] [Abstract][Full Text] [Related]
19. Chronic ethanol consumption disrupts complexation between EGF receptor and phospholipase C-gamma1: relevance to impaired hepatocyte proliferation.
Zhang BH; Farrell GC
Biochem Biophys Res Commun; 1999 Apr; 257(1):89-94. PubMed ID: 10092515
[TBL] [Abstract][Full Text] [Related]
20. Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils.
Chang LC; Huang TH; Chang CS; Tsai YR; Lin RH; Lee PW; Hsu MF; Huang LJ; Wang JP
Biochem Pharmacol; 2011 Jan; 81(2):269-78. PubMed ID: 20965153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
